Skip to main content
ORIENTBIO Inc. logo

ORIENTBIO Inc. — Investor Relations & Filings

Ticker · 002630 ISIN · KR7002630002 KO Professional, scientific and technical activities
Open in API
Filings indexed 166 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country KR South Korea
Listing KO 002630

About ORIENTBIO Inc.

https://www.orientbio.co.kr

ORIENTBIO Inc. is a biotechnology company that supports drug discovery and biomedical research. The company's core activities involve the production and supply of laboratory animal models, such as mice and rats, for pharmaceutical companies, universities, and research institutions. In addition to providing research models, ORIENTBIO offers a range of biomedical contract services, including comprehensive health checks and genetic testing. The company also develops and distributes laboratory equipment and apparatus for experimental research.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Regulatory Filings
2026-05-07 Korean
주식병합결정
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement detailing the terms and schedule of a share consolidation (reverse stock split), including pre- and post-consolidation share counts, dates for shareholder approval, trading halt, and listing. This is a capital change action specifically involving share consolidation, matching the “Share Issue/Capital Change” category (SHA).
2026-03-31 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a brief regulatory announcement in Korean regarding the setting of the shareholder register closure period (record date) for determining rights holders for an upcoming extraordinary general meeting. It does not present full meeting materials (AGM-R), earnings, dividends, or any detailed report; nor is it a report publication notice. It is a routine regulatory filing of shareholder record date information, which best fits into the fallback category of Regulatory Filings (RNS).
2026-03-31 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal convocation notice for an extraordinary general shareholders’ meeting (“임시주주총회소집결의”), listing date, venue, record date, board resolution date and agenda items for shareholder voting. This is not an earnings release, audit or annual report, nor a declaration of voting results, but rather proxy and meeting solicitation materials providing agenda details for voting. Therefore it best fits the Proxy Solicitation & Information Statement category (PSI).
2026-03-31 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a convening notice for an extraordinary shareholders’ meeting (“임시주주총회 소집공고”) and includes agenda items, voting methods (proxy and electronic), management discussion on outside directors’ activities, related-party transactions, and business overview. These materials are distributed to shareholders to provide information and solicit votes. This aligns exactly with the definition for "Proxy Solicitation & Information Statement" (Code: PSI).
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document reports changes in significant share ownership (crossing thresholds or changes in representative reporting entities). Based on the provided filing definitions, this falls under 'Major Shareholding Notification'.
2026-03-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.